Changes in characteristics and management among patients with ST-elevation myocardial infarction due to COVID-19 infection

58Citations
Citations of this article
125Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objectives: To assess changes in characteristics and management among ST-elevation myocardial infarction (STEMI) patients with coronavirus disease (COVID-19) who underwent primary percutaneous coronary intervention. Methods: Our prospective, monocentric study enrolled all STEMI patients who underwent PPCI during the COVID-19 outbreak (n = 83). This cohort was first compared with a previous cohort of STEMI patients (2008–2017, n = 1,552 patients) and was then dichotomized into a non-COVID-19 group (n = 72) and COVID-19 group (n = 11). Results: In comparison with the pre-outbreak period, patients during the outbreak period were older (59.6 ± 12.9 vs. 62.6 ± 12.2, p =.03) with a delayed seek to care (mean delay first symptoms-balloon 3.8 ± 3 vs.7.4 ± 7.7, p

Cite

CITATION STYLE

APA

Popovic, B., Varlot, J., Metzdorf, P. A., Jeulin, H., Goehringer, F., & Camenzind, E. (2021). Changes in characteristics and management among patients with ST-elevation myocardial infarction due to COVID-19 infection. Catheterization and Cardiovascular Interventions, 97(3), E319–E326. https://doi.org/10.1002/ccd.29114

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free